Maurizio D'Incalci Selected Research

Maurizio D'Incalci Research Topics

Disease

105	Neoplasms (Cancer) 02/2024 - 01/2002
29	Ovarian Neoplasms (Ovarian Cancer) 12/2023 - 04/2004
17	Sarcoma (Soft Tissue Sarcoma) 11/2020 - 12/2002
15	Myxoid Liposarcoma 01/2022 - 07/2007
12	Carcinoma (Carcinomatosis) 01/2017 - 04/2002
11	Ovarian Epithelial Carcinoma 01/2023 - 01/2012
8	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2003
7	Malignant Mesothelioma 01/2023 - 01/2017
6	Melanoma (Melanoma, Malignant) 01/2019 - 03/2003
6	Liposarcoma 01/2019 - 07/2007
5	Inflammation (Inflammations) 01/2023 - 04/2005
5	Disease Progression 01/2022 - 03/2016
5	Neoplasm Metastasis (Metastasis) 01/2020 - 08/2003
4	Mesothelioma 01/2023 - 01/2015
4	Colonic Neoplasms (Colon Cancer) 08/2020 - 02/2009
4	Multiple Myeloma 01/2019 - 04/2010
4	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 07/2012
4	Triple Negative Breast Neoplasms 01/2017 - 02/2013
4	Ewing Sarcoma (Sarcoma, Ewing) 11/2016 - 12/2002
4	Neuroblastoma 08/2012 - 10/2005
3	Neutropenia 11/2020 - 03/2005
3	Leiomyosarcoma 01/2018 - 07/2010
3	Chromosome Aberrations (Chromosome Abnormalities) 09/2009 - 12/2005
2	Fibrosarcoma 11/2021 - 08/2003
2	Glioblastoma (Glioblastoma Multiforme) 05/2019 - 10/2013
2	Adenocarcinoma 01/2018 - 03/2016
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2017 - 12/2016
2	Seizures (Absence Seizure) 03/2017 - 07/2002
2	Epilepsy (Aura) 03/2017 - 07/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2011 - 02/2008
2	Rhabdomyosarcoma 09/2010 - 09/2005

Drug/Important Bio-Agent (IBA)

57	TrabectedinIBA 02/2024 - 01/2002
15	PlatinumIBA 01/2022 - 03/2005
14	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 04/2002
12	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2003
11	Biomarkers (Surrogate Marker)IBA 05/2022 - 07/2006
10	MicroRNAs (MicroRNA)IBA 01/2023 - 07/2012
10	Paclitaxel (Taxol)FDA LinkGeneric 09/2021 - 09/2006
9	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 04/2004
8	Cisplatin (Platino)FDA LinkGeneric 07/2019 - 12/2002
7	PM 01183IBA 02/2024 - 11/2013
7	CytokinesIBA 01/2023 - 04/2005
5	ChemokinesIBA 01/2023 - 03/2010
5	Irinotecan (Camptosar)FDA LinkGeneric 11/2016 - 09/2005
4	Imatinib Mesylate (Gleevec)FDA Link 11/2017 - 05/2002
4	Gemcitabine FDA Link 01/2017 - 02/2008
4	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2016 - 08/2003
4	liposomal doxorubicin (Doxil)FDA Link 11/2016 - 08/2010
4	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2005 - 03/2003
3	Messenger RNA (mRNA)IBA 01/2023 - 07/2002
3	Circulating Tumor DNAIBA 07/2022 - 01/2018
3	Pioglitazone (Actos)FDA Link 01/2022 - 12/2019
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 08/2013
3	olaparibIBA 01/2022 - 10/2018
3	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2016
3	AnthracyclinesIBA 11/2020 - 12/2011
3	Interleukin-6 (Interleukin 6)IBA 08/2020 - 04/2005
3	RNA (Ribonucleic Acid)IBA 11/2018 - 01/2012
3	Asparaginase (Elspar)FDA Link 04/2018 - 01/2006
3	Tyrosine Kinase InhibitorsIBA 11/2017 - 02/2013
3	OTX015IBA 01/2017 - 12/2016
3	Ifosfamide FDA LinkGeneric 11/2016 - 12/2011
3	LigandsIBA 11/2015 - 11/2008
3	plitidepsin (aplidine)IBA 01/2014 - 02/2004
3	E-3810IBA 02/2013 - 02/2011
3	3- (4'- hydroxy- 3'- adamantylbiphenyl- 4- yl)acrylic acidIBA 08/2012 - 03/2007
3	RetinoidsIBA 08/2012 - 03/2007
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2011 - 11/2009
3	ST 1481 (Gimatecan)IBA 09/2010 - 10/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 04/2005
2	AsbestosIBA 01/2023 - 11/2020
2	AlkaloidsIBA 01/2022 - 03/2005
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 09/2003
2	Alanine Transaminase (SGPT)IBA 01/2021 - 10/2018
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 10/2019
2	Transaminases (Aminotransferases)IBA 11/2020 - 03/2005
2	Macrophage Colony-Stimulating FactorIBA 08/2020 - 04/2005
2	Tissue Inhibitor of Metalloproteinase-1IBA 01/2019 - 02/2015
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2018 - 08/2013
2	Carbamazepine (Tegretol)FDA LinkGeneric 03/2017 - 07/2002
2	Anticonvulsants (Antiepileptic Drugs)IBA 03/2017 - 07/2002
2	Progesterone FDA LinkGeneric 01/2017 - 08/2013
2	Estrogens (Estrogen)FDA Link 01/2017 - 08/2013
2	Transcription Factors (Transcription Factor)IBA 11/2016 - 08/2012
2	EWS-FLI fusion proteinIBA 11/2016 - 03/2014
2	Matrix Metalloproteinases (MMPs)IBA 07/2016 - 02/2013
2	Small Interfering RNA (siRNA)IBA 03/2016 - 03/2014
2	CamptothecinIBA 03/2014 - 10/2005
2	Sunitinib (Sutent)FDA Link 10/2013 - 02/2011
2	Phosphotransferases (Kinase)IBA 02/2013 - 02/2011
2	delanzomibIBA 01/2013 - 11/2010
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2012 - 09/2011
2	Fluorouracil (Carac)FDA LinkGeneric 09/2011 - 02/2009

Therapy/Procedure

31	Therapeutics 04/2022 - 08/2007
23	Drug Therapy (Chemotherapy) 01/2022 - 12/2002
5	Aftercare (After-Treatment) 01/2022 - 12/2002
3	Immunotherapy 01/2022 - 01/2020
2	Cytoreduction Surgical Procedures 01/2022 - 07/2019
2	Hyperthermic Intraperitoneal Chemotherapy 07/2019 - 01/2017
2	Salvage Therapy 03/2016 - 03/2005